Toxic shock syndrome overview

Jump to navigation Jump to search

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome overview

CDC on Toxic shock syndrome overview

Toxic shock syndrome overview in the news

Blogs on Toxic shock syndrome overview

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2], Syed Hassan A. Kazmi BSc, MD [3]

Overview

Toxic shock syndrome (TSS) is a rare, but potentially fatal disease caused by bacterial toxins. Different bacterial toxins may cause toxic shock syndrome, depending on the situation. The causative agents are the Gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes. Streptococcal TSS is sometimes referred to as toxic shock-like-syndrome (TSLS) . Some cases maybe caused by Clostridium sordellii, influenza virus and varicella zoster virus. The syndrome consists of sudden onset of fever, chills, vomiting, diarrhea, muscle aches, hypotension and a scarlantiform rash. Diagnosis of toxic Shock Syndrome (TSS) is mainly based on the clinical presentation. The initial management of toxic shock syndrome involves the removal of any foreign materials such as tampons, vaginal sponges, or nasal packing. Antimicrobial therapy is indicated in toxic shock syndrome. Supportive therapy for toxic shock syndrome includes intravenous fluids, control of blood pressure, and dialysis in cases of renal failure. Patients with multiple organ failure are admitted to the intensive care unit.

Historical Perspective

The term toxic shock syndrome was first used in 1978 by a Denver pediatrician, Dr. J.K. Todd, to describe the staphylococcal illness in three boys and four girls aged 8-17 years.[1] Even though S. aureus was isolated from mucosal sites from the patients, bacteria could not be isolated from the blood, cerebrospinal fluid, or urine, raising suspicion that a toxin was involved. The authors of the study noted that reports of similar staphylococcal illnesses had appeared occasionally as far back as 1927. Most notably, the authors at the time failed to consider the possibility of a connection between toxic shock syndrome and tampon use, as three of the girls who were menstruating when the illness developed were using tampons.[2]

Classification

Toxic shock syndrome may be classified based on the microbiological organisms involved in causing the disease. Commonly involved organisms are Staphylococcus aureus and Streptococcus pyogenes (GAS). Less commonly involved organisms leading to the development of toxic shock syndrome are Clostridium sordelliInfluenza and Varicella Zoster virus (the etiological agent of chickenpox).

Pathophysiology

The pathophysiology of toxic shock syndrome can be explained based on the etiological agent causing the disease. The general mechanism for all the etiological agents is the same, which involves non-specific activation of T lymphocytes by toxins acting as superantigens leading to release of cytokines. There are small differences in the mechanism of cytokine production which can be explained individually for the organisms involved.

Causes

Toxic shock syndrome is caused by a toxin produced by certain types of Staphylococcus bacteria. A similar syndrome, called toxic shock-like syndrome (TSLS), can be caused by streptococcal bacteria. Some cases of toxic shock syndrome have been known to be caused by Clostridium sordellii, influenza virus and varicella zoster virus.

Differentiating Toxic Shock Syndrome from other Diseases

Toxic shock syndrome (TSS) may have a similar presentation to some diseases which present as a rash, fever and hypotension. Some features are unique to toxic shock syndrome and can be used to differentiate it from other diseases.

Epidemiology and Demographics

Toxic shock syndrome (TSS) became a nationally notifiable disease in 1980. After the initial epidemic, the number of reported cases decreased significantly. Close observation during 1986 which was conducted in different parts of the United States, confirms the decreasing trend. Currently, the total incidence is 0.5 per 100,000 population. Incidence rates declined from 6 to 12 per 100,000 among women 12-49 years of age in 1980 to 1 per 100,000 among women 15-44 years of age in 1986.[1] Apart from menstruation associated TSS, non-menstruating cases having a skin or soft tissue infection have also been identified.[2]

Risk Factors

Menstruating women, women using barrier contraceptive devices, persons who have undergone nasal surgery, and persons with postoperative staphylococcal wound infections are the most important risk factors for toxic shock syndrome.

Natural History, Complication and Prognosis

If left untreated toxic shock syndrome after initial presentation, may rapidly lead to multi-organ system failure with serious morbidity and mortality. Appropriate treatment leads to full recovery of the patient.

Diagnosis

Diagnostic Criteria

Diagnosis of Toxic Shock Syndrome (TSS) is mainly based on the clinical presentation.

History and Symptoms

The most common symptoms of TSS include fever, erythroderma, and general viral infection symptoms like myalgia. Less common symptom of TSS include desquamation (which occur after 1-3 weeks of disease onset).

Physical Examination

Patients with toxic shock syndrome (TSS) usually present with shockPhysical examination of patients with TSS is usually remarkable for hypotensionfever, and diffuse erythroderma. The presence of desquamation on physical examination is highly suggestive of TSS.

Laboratory Findings

Laboratory findings consistent with the diagnosis of toxic shock syndrome (TSS) include leukocytosisanemia and thrombocytopenia. A positive blood culture is diagnostic for Streptococcal TSS, although in other causes of TSS blood culture doesn't have a high value.

X-Rays

Different imaging methods can be used during toxic shock syndrome (TSS) evaluation which are more useful to assess the disease complications. CXR can be used to diagnose early pulmonary complications.

CT Scan

Different imaging methods can be used during toxic shock syndrome (TSS) evaluation which are more useful to assess the disease complications. Brain CT scan can be used to diagnose cerebral edema as a major dangerous complication.

MRI

There are no indication for MRI usage in toxic shock syndrome (TSS) diagnosis.

Other Imaging Studies

There are no other specific imaging findings​ for toxic shock syndrome (TSS).

Other Diagnostic Studies

Although the best diagnostic tool for toxic shock syndrome (TSS) diagnosis is with clinical findings and laboratory exams, there are still some specific diagnostic ways to confirm TSS diagnosis. These techniques include frozen section biopsy and staphylococcus aureus antibody testing.

Treatment

Medical Therapy

Women wearing a tampon at the onset of symptoms should remove it immediately. The severity of this disease results in hospitalization for treatment. Antibiotic treatment consists of penicillin and clindamycin.

Surgery

One of the symptoms of streptococcal toxic shock syndrome is extreme infection of the skin and deeper parts is called necrotizing fasciitis. This often requires prompt surgical treatment.

Primary Prevention

Menstrual toxic shock syndrome can be prevented by avoiding the use of highly absorbent tampons. Risk can be reduced by changing tampons more frequently and using tampons only once in a while during menstruation.

Secondary Prevention

Secondary prevention strategies following toxic shock syndrome (TSS) include chemoprophylaxis for invasive group A streptococcus or staphylococcuscarriers. Although it is still not certain to be helpful.

References


Template:WikiDoc Sources